BIOTRICITY INC by Biotricity Inc. Analyst Price Targets - Benzinga

BIOTRICITY INC by Biotricity Inc.

BTCYOTCQB

Trade with Public

Trade with Public

$0.4631

At close: Aug 12, 5:00 PM EST

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare

BIOTRICITY INC by Biotricity Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for BIOTRICITY INC by Biotricity Inc. (BTCY).

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 18, 2024	HC Wainwright & Co.	Kevin Dede	Maintained	Neutral	—
Nov 20, 2023	HC Wainwright & Co.	Kevin Dede	Downgrade	Buy→Neutral	—

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Biotricity

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Downgrades Biotricity to Neutral

HC Wainwright & Co. analyst Kevin Dede downgrades Biotricity (NASDAQ:BTCY) from Buy to Neutral.

Benzinga Newsdesk

Biotricity Predicted To Achieve 44% Annual Growth Despite Market Risks, Analyst Says

Nabaparna Bhattacharya

PRO
HC Wainwright & Co. Reiterates Buy on Biotricity, Raises Price Target to $4

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and raises the price target from $2 to $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and maintains $2 price target.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Benzinga Insights